The impact of ocular surface disease in glaucoma treatment
This article considers the impact of ocular surface disease on patients with glaucoma and the implications it can have on quality of life and adherence to treatment
28 April 2018
To view this content, please log in.
Not a member or subscriber? Join AOP today for access to a whole range of benefits, or subscribe to OT for immediate access to our premium content.